FDA-Approved COVID Testing Roundup | MedTruth - Prescription Drug & Medical Device Safety | Informed Advocacy

The U.S. Food and Drug Administration (FDA) has approved the first generic version of Johnson & Johnson’s HIV drug Prezista. The generic drug, manufactured by Apotex Inc., is now available to patients at a lower cost. Prezista is a once-daily pill that is used to treat adults with HIV. It is part of a class of drugs called integrase inhibitors, which work by blocking the virus from integrating its genetic material into the host cell’s DNA.

  • FDA Warns About Risk of Liver Injury From Popular Weight Loss Drug Belviq The FDA has issued a warning about the risk of liver injury from the weight loss drug Belviq. The agency said that there have been reports of serious liver injury, including liver failure, in patients taking Belviq. The FDA is now requiring that the drug’s label be updated to include a warning about the risk of liver injury. Belviq is a prescription drug that is used to help people lose weight. It works by increasing the feeling of fullness and decreasing appetite.
  • FDA Grants Emergency Use Authorization for Monkeypox Vaccine The FDA has granted emergency use authorization (EUA) for the Jynneos monkeypox vaccine. The vaccine is now available to people who are at high risk of exposure to monkeypox. Monkeypox is a rare but serious viral illness that is similar to smallpox. It is spread through contact with the bodily fluids of an infected person. The Jynneos vaccine is a two-dose vaccine that is 85% effective in preventing monkeypox.Jynneos monkeypox vaccine
  • FDA Issues Safety Communication About Risk of Serious Side Effects From Antipsychotic Drugs The FDA has issued a safety communication about the risk of serious side effects from antipsychotic drugs. The agency said that there have been reports of death, stroke, and heart attack in patients taking antipsychotic drugs. The FDA is now requiring that the drugs’ labels be updated to include a warning about the risk of these serious side effects. Antipsychotic drugs are used to treat a variety of mental health conditions, including schizophrenia, bipolar disorder, and major depressive disorder.Antipsychotic drugs
  • FDA Announces New Initiative to Address the Opioid Crisis The FDA has announced a new initiative to address the opioid crisis. The initiative, called the Opioid Safety and Access Network (OSAN), will focus on improving the safety and availability of opioid medications. OSAN will work to reduce the number of opioid-related deaths, improve the treatment of pain, and prevent the misuse of opioid medications.

These are just a few of the top FDA news headlines for today. The FDA is committed to protecting the public health and safety, and it is working to ensure that patients have access to safe and effective medications.